US 8106232
3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
granted A61KA61K31/197A61K31/485
Quick answer
US patent 8106232 (3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists) held by Theravance, Inc. expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/197, A61K31/485, A61K45/06, A61K47/02